Skip to main content
FinSpry Logo
FinSpry
TEVA logo
TEVA
(NYSE)
Teva Pharmaceutical Industries Limited
$30.08-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Teva Pharmaceutical Industries Limited (TEVA) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Teva Pharmaceutical Industries Limited stock.

Analyst Consensus Rating

Investment consensus from 6 professional research analysts

Consensus Rating

Strong Buy
Based on 6 unique analysts
(7 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$41.00
↑ 36.30% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest TEVA Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

David Amsellem
Piper Sandler
BuyReiterates
$40.00 → $41.00
Les Sulewski
Truist
Strong BuyMaintains
$38.00 → $42.00
Matt Dellatorre
Goldman Sachs
Strong BuyMaintains
$36.00 → $45.00
Glen Santangelo
Barclays
BuyMaintains
$35.00 → $38.00
Louise Chen
Scotiabank
BuyMaintains
$35.00 → $40.00
Les Sulewski
Truist
Strong BuyMaintains
$36.00 → $38.00
Glen Santangelo
Jefferies
Strong BuyMaintains
$29.00 → $40.00

Frequently Asked Questions

What is the analyst consensus rating for TEVA?

The analyst consensus rating for TEVA is "Strong Buy" based on 6 analyst recommendations.

What is the average price target for TEVA?

The average 12-month price target for TEVA is $41.00, representing an upside of 36.3% from the current price of $30.08.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.